Aratana Therapeutics, Inc.
PETX
PETX was delisted on the 17th of July, 2019.
81 hedge funds and large institutions have $396M invested in Aratana Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 31 increasing their positions, 9 reducing their positions, and 1 closing their positions.
3,500% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 1
244% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 9
76% more funds holding
Funds holding: 46 → 81 (+35)
73% more capital invested
Capital invested by funds: $229M → $396M (+$167M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$31.4M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$16.6M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$16.6M |
| 4 |
DM
Deerfield Management
New York
|
+$15.8M |
| 5 |
BC
Broadfin Capital
New York
|
+$13.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
-$31.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$13M |
| 3 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
-$2M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$348K |
| 5 |
JP Morgan Chase
New York
|
-$244K |
PETX Hedge Fund Activity: Q1 2014 in Review
81 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q1 2014, worth a combined $396M — up 73% from $229M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new PETX positions and 1 closed out — a net gain of 35 holders — while 31 added to existing stakes and 9 trimmed.
The largest buyer was Franklin Resources, adding an estimated $31.4M. The largest seller was MPM Asset Management, cutting an estimated $31.3M.
- 81 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q1 2014, up from 46 in Q4 2013.
- Funds reported $396M of Aratana Therapeutics, Inc. stock for Q1 2014, up 73% quarter-over-quarter.
- 36 funds opened new Aratana Therapeutics, Inc. positions in Q1 2014 and 1 closed out, a net change of +35 holders.
- The largest Aratana Therapeutics, Inc. buyer in Q1 2014 was Franklin Resources, an estimated $31.4M added.
- The largest Aratana Therapeutics, Inc. seller in Q1 2014 was MPM Asset Management, an estimated $31.3M sold.
Based on aggregated 13F filings for Q1 2014.